bpc 157 affects BPC-157: Tendon Repair and More Frontiers | Stable Gastric Pentadecapeptide
Description
Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157
You are to able resume normal activities immediately after the injection as well
des doses extrmement leves (plus de 2g/jour), des troubles nerveux sensoriels et moteurs (neuropathies) peuvent survenir, comme la perte de rflexes
From the Orrick analysis published April 16: removal from Category 2 does not, by itself, place these substances on the 503A bulks list or into Category 1 for which FDA is exercising enforcement discretion
That makes them especially useful for men who dont absorb B12 well from food or pills
